PharmaCyte Biotech (FEMY) reports 7.87% stake including warrants

NodeGuardian · 2026-03-19T05:28:33+00:00

PharmaCyte Biotech, Inc. owns 7.87% of Femasys Inc. shares, including 695,537 shares and warrants for 4,237,288 more. An amendment to Schedule 13D notes Joshua Silverman's resignation from Femasys' Board and indicates no intent to influence control.

NodeGuardian

2026-03-19 05:28:33

Abstract generation in progress

PharmaCyte Biotech, Inc. has reported a beneficial ownership of 4,932,825 shares of Femasys Inc. common stock, which represents 7.87% of the class. This stake includes 695,537 currently held shares and Series A warrants exercisable for an additional 4,237,288 shares, subject to a 19.99% beneficial ownership limitation. The filing is an amendment to a previous Schedule 13D, noting that Joshua Silverman resigned from Femasys’ Board of Directors, and PharmaCyte Biotech no longer holds securities with the purpose of changing or influencing control of the issuer.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

1 Likes